Late recurrences of germ cell malignancies: A population-based experience over three decades

British Journal of Cancer

Volumn 94, Issue 6, 2006, Pages 820-827

  Oldenburg, J ^a,b   Alfsen, G C ^b   Waehre H ^b   Fossa S D ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

EGGCT; Extragonadal germ cell cancer; Late recurrence; Late relapse; Non seminoma; Retroperitoneal lymph node dissection; Seminoma; Testicular cancer

Indexed keywords

ALKYLATING AGENT; BLEOMYCIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; TUMOR MARKER; VINBLASTINE; VINCRISTINE SULFATE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; GERM CELL TUMOR; HISTOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MEDICAL RECORD REVIEW; POPULATION RESEARCH; PRIORITY JOURNAL; SALVAGE THERAPY; SEMINOMA; SURVIVAL TIME; TERATOMA; TUMOR NECROSIS;

ADULT; AGED; COHORT STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NECROSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GERM CELL AND EMBRYONAL; SEMINOMA; TESTICULAR NEOPLASMS; TIME FACTORS;

EID: 33645327685     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603014     Document Type: Article

References (30)

1. Aass N, Klepp O, Cavallin-Stahl E, Dahl O, Wicklund H, Unsgaard B, Baldetorp L, Ahlstrom S, Fossa SD (1991) Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience. J Clin Oncol 9: 818-826
2. Baniel J, Foster RS, Gonin R, Messemer JE, Donohue JP, Einhorn LH (1995) Late relapse of testicular cancer. J Clin Oncol 13: 1170-1176
3. Borge N, Fossa SD, Ous S, Stenwig AE, Lien HH (1988) Late recurrence of testicular cancer. J Clin Oncol 6: 1248-1253
4. Collette L, Sylvester RJ, Stenning SP, Fossa SD, Mead GM, de Wit R, de Mulder PH, Neymark N, Lallemand E, Kaye SB (1999) Impact of the treating institution on survival of patients with 'poor-prognosis' metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party. J Natl Cancer Inst 91: 839-846
5. Damjanov I, Amenta PS, Zarghami F (1984) Transformation of an Afp-positive yolk-sac carcinoma into an Afp-negative neoplasm - evidence for in vivo cloning of the human parietal yolk-sac carcinoma. Cancer 53: 1902-1907
6. Dieckmann KP, Albers P, Classen J, De Wit M, Pichlmeier U, Rick O, Mullerleile U, Kuczyk M (2005) Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases. J Urol 173: 824-829
7. Donohue JP, Foster RS, Rowland RG, Bihrle R, Jones J, Geier G, Jewett MAS (1990) Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol 144: 287-292
8. Fossa SD, Dahl AA, Loge JH (2003) Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J Clin Oncol 21: 1249-1254
9. Fossa SD, Ous S (1985) Primary unilateral retroperitoneal lymph node dissection [RLND] in non-seminomatous testicular cancer. Prog Clin Biol Res 203: 319
10. Fossa SD, Ous S, Lien HH, Stenwig AE (1989) Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer. J Urol 141: 557-559
11. Fossa SD, Qvist H, Stenwig AE, Lien HH, Ous S, Giercksky KE (1992) Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses? J Clin Oncol 10: 569-573
12. George DW, Foster RS, Hromas RA, RObertson KA, Vance GH, Ulbright TM, Gobbett TA, Heiber DJ, Heerema NA, Ramsey HC, Thurston VC, Jung SH, Shen JZ, Finch DE, Kelley MP, Einhorn LH (2003) Update on late relapse of germ cell tumor: A clinical and molecular analysis. J Clin Oncol 21: 113-122
13. Gerl A, Clemm C, Schmeller N, Hentrich M, Lamerz R, Wilmanns W (1997) Late relapse of germ cell tumors after cisplatin-based chemotherapy. Ann Oncol 8: 41-47
14. IGCCCG (1997) International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 15: 594-603
15. Jacobsen KD, Ous S, Waehre H, Trasti H, Stenwig AE, Lien HH, Aass N, Fossa SD (1999) Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection. Br J Cancer 80: 249-255
16. Lipphardt ME, Albers P (2004) Late relapse of testicular cancer. World J Urol 22: 47-54
17. Michael H, Lucia J, Foster RS, Ulbright TM (2000) The pathology of late recurrence of testicular germ cell tumors. Am J Surg Pathol 24: 257-273
18. Murphy BR, Breeden ES, Donohue JP, Messemer J, Walsh W, Roth BJ, Einhorn LH (1993) Surgical salvage of chemorefractory germ cell tumors. J Clin Oncol 11: 324-329
19. Nichols CR (1999) Treatment of recurrent germ cell tumors. Semin Surg Oncol 17: 268-274
20. Oldenburg J, Alfsen GC, Lien HH, Aass N, Waehre H, Fossa SD (2003) Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol 21: 3310-3317
21. Sagstuen H, Aass N, Fossa SD, Dahl O, Klepp O, Wist EA, Wilsgaard T, Bremnes RM (2005) Blood pressure and body mass index in long-term survivors of testicular cancer 28. J Clin Oncol 23: 4980-4990
22. Shahidi M, Norman AR, Dearnaley DP, Nicholls J, Horwich A, Huddart RA (2002) Late recurrence in 1263 men with testicular germ cell tumors. Multivariate analysis of risk factors and implications for management. Cancer 95: 520-530
23. Sobin LH, Wittekind Ch (2002) UICC, International Union against Cancer. TNM Classification of Malignant Tumours. Wiley-Liss: New York
24. Stephenson AJ, Sheinfeld J (2004) The role of retroperitoneal lymph node dissection in the management of testicular cancer. Urologic Oncol-Semin Original Invest 22: 225-233
25. Travis LB, Fossa SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, Hall P, Holowaty E, Andersen A, Pukkala E, Andersson M, Kaijser M, Gospodarowicz M, Joensuu T, Cohen RJ, Boice Jr JD, Dores GM, Gilbert ES (2005) Second cancers among 40 576 testicular cancer patients: focus on long-term survivors 4. J Natl Cancer Inst 97: 1354-1365
26. Ulbright Thomas M, Amin Mahul B, Young Robert H (1999) Tumors of the Testis, Adnexa, Spermatic Cord, and Scrotum. Armed Forces Institute of Pathology: Washington, DC
27. Ustun M, Heilo A, Fossa S, Aass N, Berner A (2002) Ultrasound-guided fine needle cytology of retroperitoneal masses in patients with malignant germ cell tumours: diagnosis and therapeutic impact. Eur Urol 42: 221-228
28. van der Gaast A, Hoekstra JW, Croles JJ, Splinter TA (1991) Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma. J Urol 145: 829-831
29. Vaughn DJ, Gignac GA, Meadows AT (2002) Long-term medical care of testicular cancer survivors. Ann Inter Med 136: 463-470
30. Whitmore Jr WF (1979) Surgical treatment of adult germinal testis tumors. Semin Oncol 6: 55-68